What is the initial preparation and dosage for a norepinephrine (vasopressor) drip order?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Drip Order

Prepare norepinephrine by adding 4 mg to 250 mL of D5W (yielding 16 μg/mL concentration), start the infusion at 8-12 μg/min (2-3 mL/min), and titrate to achieve a mean arterial pressure of 65 mmHg. 1, 2

Standard Preparation

  • Add 4 mg of norepinephrine to 250 mL of D5W to create a concentration of 16 μg/mL 1, 3
  • Alternative standard concentration: Add 4 mg to 1000 mL of D5W for a 4 μg/mL solution 1
  • Do not dilute in saline alone—dextrose-containing solutions are required to prevent oxidation and loss of potency 1
  • Solutions remain chemically stable for 7 days at room temperature under ambient light in either D5W or normal saline 4

Initial Dosing

  • Start at 8-12 μg/min (equivalent to 2-3 mL/min of the 16 μg/mL solution) 1
  • After observing initial response, adjust to maintenance dose of 2-4 μg/min (0.5-1 mL/min) 1
  • Typical dosing range for septic shock: 0.1-2 mcg/kg/min 3
  • Maximum doses can reach 3 mg/hour or higher if hypotension persists, though occult hypovolemia must be ruled out 1, 3

Critical Pre-Administration Requirements

  • Correct hypovolemia with crystalloid boluses (minimum 30 mL/kg) before or concurrent with vasopressor initiation 3, 1
  • Vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure readings 3
  • Central venous pressure monitoring helps detect and treat occult volume depletion 1

Administration Route

  • Central venous access is strongly preferred to minimize extravasation risk 3, 1
  • If central access is unavailable, peripheral IV can be used temporarily with strict site monitoring 3
  • Use a large vein with a plastic IV catheter advanced centrally and securely fixed 1
  • An IV drip chamber or metering device is essential for accurate flow rate measurement 1

Target Blood Pressure

  • Target mean arterial pressure (MAP) of 65 mmHg for septic shock 2, 3
  • For previously hypertensive patients, raise blood pressure no higher than 40 mmHg below pre-existing systolic pressure 1
  • Alternative targets: systolic blood pressure 80-100 mmHg or increase MAP by 10 mmHg with urine output >50 mL/h 3

Monitoring Protocol

  • Monitor blood pressure and heart rate every 5-15 minutes during initial titration 3
  • Place arterial catheter as soon as practical for continuous monitoring 2
  • Watch for signs of excessive vasoconstriction: cold extremities, decreased urine output, tissue ischemia 3, 1
  • Monitor for arrhythmias and hypertension 3

Titration Guidelines

  • Titrate dose based on blood pressure response and tissue perfusion 1
  • Increase by 0.5 mg/h every 4 hours as needed, up to maximum 3 mg/h 3
  • Reduce infusion gradually when discontinuing—avoid abrupt withdrawal 1
  • Continue until adequate blood pressure and tissue perfusion are maintained without therapy 1

Extravasation Management

  • If extravasation occurs, immediately infiltrate phentolamine 5-10 mg diluted in 10-15 mL saline into the affected site 3, 1
  • Pediatric phentolamine dose: 0.1-0.2 mg/kg up to 10 mg 3
  • Norepinephrine can cause tissue necrosis and sloughing if extravasation is not promptly treated 3

Important Precautions

  • Do not mix norepinephrine with sodium bicarbonate or alkaline solutions—they inactivate the drug 3, 1
  • Avoid contact with iron salts, alkalis, or oxidizing agents 1
  • Do not use if solution is pinkish, darker than slightly yellow, or contains precipitate 1
  • Norepinephrine is the first-choice vasopressor over dopamine, epinephrine, or phenylephrine for initial management 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Norepinephrine Drip Administration Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Stability of norepinephrine infusions prepared in dextrose and normal saline solutions.

Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.